Skip over main navigation
  • Sign up
  • Log in
  • Basket: (0 items)
Leukaemia UK
  • Search
  • Facebook
  • Twitter
  • Instagram
Contact us Donate
Menu
  • Home
  • About us
    • How we make a difference
    • News
    • Our history
    • Who we are
      • Staff
      • Trustees
      • Scientific and Medical Panel
      • Vacancies
    • Reports and Accounts
    • Contact us
  • About blood cancers
    • Leukaemia
    • Lymphoma, myeloma and other blood cancers
    • Your stories
    • Clinician stories
  • Research & care
    • Leukaemia research
    • Other blood cancer research
    • Clinical trials
    • Mind and Body
    • Research funding opportunities
    • Research strategy
    • Our care projects
  • Get involved
    • Fundraising events and challenges
    • Set up your own fundraising page
    • Who's Cooking Dinner?
    • Get your company involved
    • Volunteer for us
    • Supporter stories
  • Ways to give
    • Donate now
    • Donate in memory
    • Leave a gift in your will
    • Donate through your salary
    • Special Occasion Giving
    • Find a donation page
      • In memory of someone special
      • Event Fundraisers
    • Other ways to donate
    • Leukaemia UK e-cards
  • Admin
    • Log in
  • Basket: (0 items)
  1. Research & care
  2. Leukaemia research

Research into leukaemia

Leukaemia UK believes in the power of research to discover kinder, more effective treatments for leukaemia as we work towards a cure. Thanks to research, leukaemia survival is improving and has more than quadrupled in the past 40 years in the UK. With your help, we fund cutting-edge research in the UK and beyond, which is crucial to finding breakthroughs and cures for leukaemia.

AML: Development and characterisation of a new class of drugs targeting the RNA methyltransferase METTL3

AML: Development and characterisation of a new class of drugs targeting the RNA methyltransferase METTL3

Dr Kostas Tzelepis, University of Cambridge and John Goldman Fellow Read more

Published: 8th September, 2000

Updated: 9th December, 2020

Author: Margarita Vidiella

Related topics:
  • Research into leukaemia
AML: Understanding gene activation to find novel therapeutic targets

AML: Understanding gene activation to find novel therapeutic targets

Dr Bettina Wingelhofer, University of Manchester and John Goldman Fellow Read more

Published: 5th August, 2016

Updated: 9th December, 2020

Author: Margarita Vidiella

Related topics:
  • Research into leukaemia
Leukaemia: Understanding premalignant stages

Leukaemia: Understanding premalignant stages

Dr Miguel Ganuza, Queen Mary University of London and John Goldman Fellow Read more

Published: 4th August, 2017

Updated: 9th December, 2020

Author: Margarita Vidiella

Related topics:
  • Research into leukaemia
Targeting natural killer cells for the treatment of leukaemia

Targeting natural killer cells for the treatment of leukaemia

Dr Matthew Blunt, University of Southampton and John Goldman Fellow Read more

Published: 28th October, 2019

Updated: 17th December, 2020

Author: Amy Machin

Related topics:
  • Research into leukaemia
AML: A better understanding of leukaemia stem cells

AML: A better understanding of leukaemia stem cells

Dr Xu Huang, Paul O’Gorman Leukaemia Research Centre, University of Glasgow and John Goldman Fellow Read more

Published: 29th October, 2019

Updated: 9th December, 2020

Author: Margarita Vidiella

Related topics:
  • Research into leukaemia
MDS & AML: Is DNA damage repair leading to cancer?

MDS & AML: Is DNA damage repair leading to cancer?

Prof. Ken Mills, Queens University Belfast and Leukaemia UK Project Grant Read more

Published: 1st November, 2019

Updated: 9th December, 2020

Author: Margarita Vidiella

Related topics:
  • Research into leukaemia
AML: What is the role of the GATA2 protein?

AML: What is the role of the GATA2 protein?

Dr Salima (Sarah) Nurmohamed, University of Oxford and John Goldman Fellow Read more

Published: 1st November, 2019

Updated: 9th December, 2020

Author: Margarita Vidiella

Related topics:
  • Research into leukaemia
AML: Genes that could switch off leukaemia cells

AML: Genes that could switch off leukaemia cells

Dr Cristina Pina, University of Cambridge and John Goldman Fellow Read more

Published: 1st November, 2019

Updated: 9th December, 2020

Author: Margarita Vidiella

Related topics:
  • Research into leukaemia
AML: What is the importance of vascular niches?

AML: What is the importance of vascular niches?

Dr Anjali Kusumbe, University of Oxford and John Goldman Fellow Read more

Published: 1st November, 2019

Updated: 9th December, 2020

Author: Margarita Vidiella

Related topics:
  • Research into leukaemia
AML: How do leukaemia cells avoid the Notch pathway?

AML: How do leukaemia cells avoid the Notch pathway?

Dr Fernando dos Anjos Afonso, European Cancer Stem Cell Research Institute, Cardiff and John Goldman Fellow Read more

Published: 1st November, 2019

Updated: 9th December, 2020

Author: Margarita Vidiella

Related topics:
  • Research into leukaemia
ALL: Investigating a new genetic abnormality

ALL: Investigating a new genetic abnormality

Dr Lisa J Russell, Northern Institute for Cancer Research and John Goldman Fellow Read more

Published: 1st November, 2019

Updated: 9th December, 2020

Author: Margarita Vidiella

Related topics:
  • Research into leukaemia
ALL: FAT1, a promising new target for therapy?

ALL: FAT1, a promising new target for therapy?

Dr Sunniyat Rahman, UCL Cancer Institute and John Goldman Fellow Read more

Published: 1st November, 2019

Updated: 9th December, 2020

Author: Margarita Vidiella

Related topics:
  • Research into leukaemia
Acute Leukaemia: A potential game changer for treating infant and adult leukaemias

Acute Leukaemia: A potential game changer for treating infant and adult leukaemias

Dr Owen Williams, UCL Institute of Child Health and Leukaemia UK Project Grant Read more

Published: 1st November, 2019

Updated: 9th December, 2020

Author: Margarita Vidiella

Related topics:
  • Research into leukaemia
CML: Vulnerabilities in leukaemia stem cells

CML: Vulnerabilities in leukaemia stem cells

Dr Vignir Helgason, Wolfson Wohl Cancer Research Centre, University of Glasgow and John Goldman Fellow Read more

Published: 1st November, 2019

Updated: 9th December, 2020

Author: Margarita Vidiella

Related topics:
  • Research into leukaemia
CLL: Unravelling the regulation of surface proteins and signalling inside CLL cells

CLL: Unravelling the regulation of surface proteins and signalling inside CLL cells

Dr Sergey Krysov, Barts Cancer Institute & Centre for Haemato-Oncology, Queen Mary Hospital, London and John Goldman Fellow Read more

Published: 1st November, 2019

Updated: 9th December, 2020

Author: Margarita Vidiella

Related topics:
  • Research into leukaemia
CLL: Identifying what causes therapy resistance

CLL: Identifying what causes therapy resistance

Dr Adam Linley, University of Liverpool and John Goldman Fellow Read more

Published: 1st November, 2019

Updated: 9th December, 2020

Author: Margarita Vidiella

Related topics:
  • Research into leukaemia
CLL: Investigating the role of antigen exposure in the development and expansion of Chronic Lymphocytic Leukaemia

CLL: Investigating the role of antigen exposure in the development and expansion of Chronic Lymphocytic Leukaemia

Dr Robbert Hoogeboom, Kings College London and John Goldman Fellow Read more

Published: 26th October, 2020

Updated: 9th December, 2020

Author: Amy Machin

Related topics:
  • Research into leukaemia
CMML: Using technology to generate unlimited cells to identify new drugs

CMML: Using technology to generate unlimited cells to identify new drugs

Professor Jacqueline Boultwood, University of Oxford and Leukaemia UK Project Grant Read more

Published: 26th October, 2020

Updated: 9th December, 2020

Author: Amy Machin

Related topics:
  • Research into leukaemia
MLL: Identifying how Mixed Lineage Leukaemia resists chemotherapy treatment

MLL: Identifying how Mixed Lineage Leukaemia resists chemotherapy treatment

Dr Maria Teresa Esposito, University of Roehampton and John Goldman Fellow Read more

Published: 27th October, 2020

Updated: 9th December, 2020

Author: Amy Machin

Related topics:
  • Research into leukaemia
Back to top

Showing 10 of 19

Latest

  • Remembering Rosie

    Remembering Rosie

    Mum diagnosed with AML before she passed due to Covid

  • Lizell's London Landmarks for Leukaemia UK

    Lizell's London Landmarks for Leukaemia UK

    I am fundraising for Leukaemia UK because my sister's best friend Alice, unfortunately is fighting the disease. I am running the half marathon as it will be a tough challenge for me but I know it will be nothing like what Alice has been through already.

  • Roger Baker

    Roger Baker

    In memory of my dad Roger Baker.

  • Betty Platt

    My mother recently passed away from chronic lymphocytic leukaemia and I would like to raise funds to continue ongoing research

Most read

  • Donate now

    Donate now

    Your donation will enable us to fund the most innovative research and ensure we can provide the best support for those affected by leukaemia and other blood cancers

  • Hodgkin lymphoma: Yasmin's story

    Hodgkin lymphoma: Yasmin's story

    When Yasmin was diagnosed with Hodgkin lymphoma three years ago, she felt anxious about the months of treatment ahead. But now, with a wedding to plan and fresh outlook on life, we are delighted share her inspiring story.

  • Mind & Body

    Mind & Body

    Any cancer diagnosis is a shock, but the treatments for leukaemia and other blood cancers can be particularly demanding and isolating. We want all families to have access to emotional and wellbeing support

  • Why our work is vital

    Why our work is vital

    Leukaemia UK funds ground-breaking research and care for those affected by leukaemia and other blood cancers. Find out about our life-saving work

  • Donate in memory

    Donate in memory

    Celebrate the life of a loved one while supporting our vital work

  • Our history

    Our history

    Leuka and Leukaemia UK have merged to create a new charity dedicated to ground-breaking blood cancer research and care

  • Virgin Money London Marathon: October 2021

    Virgin Money London Marathon: October 2021

    Run the most prestigious marathon in the world for Leukaemia UK. Our 2020 team is now full

  • Our work matters

    Our work matters

    We make a difference to those affected by leukaemia, myeloma, lymphoma and other blood cancers. Find out about our life saving work

  • Kenza: I learned leukaemia can affect anyone

    Kenza: I learned leukaemia can affect anyone

    Kenza overcame gruelling conditions to complete the London Marathon to raise funds for Leukaemia UK after her brother Jos was diagnosed with acute myeloid leukaemia at the age of 17

  • Kathryn's story: diagnosed with Hodgkin lymphoma at 22

    Kathryn's story: diagnosed with Hodgkin lymphoma at 22

    Counselling and the support of her family helped Kathryn find a positive new way of life following her treatment

Donate in memory

Donate in memory

Celebrate the life of a loved one while supporting our vital work Read more

Published: 23rd August, 2017

Updated: 11th February, 2020

Author: Margarita Vidiella

Get involved

Get involved

Discover our exciting events calendar Read more

Published: 20th September, 2017

Updated: 4th August, 2020

Author: Margarita Vidiella

Related topics:
  • Latest news
Scott's acute lymphoblastic leukaemia story

Scott's acute lymphoblastic leukaemia story

Scott was diagnosed with acute lymphoblastic leukaemia after collapsing at a work event. Read his story here Read more

Published: 9th September, 2019

Updated: 4th August, 2020

Author: Margarita Vidiella

Sign up for our newsletter

Leukaemia UK
52 Portland Place, London, W1B 1NH

Telephone: 020 7299 0722 
Email: [email protected]

Registered Charity Number 1154856 

Please note that due to the Social Distancing guidelines introduced by the Government we now have limited access to our office. Our team remains available to reply to calls/emails during our working hours Monday - Friday 9:00am - 5:30pm. We will reply to any correspondence sent to our office as soon as possible. Thank you for bearing with us.


  • Facebook
  • Twitter
  • Instagram
  • Contact us
  • Sitemap
  • Accessibility
  • Terms and Conditions
  • Privacy Policy